Presented by Tim McCready of BioPacific Ventures, this is the first of two workshop sessions focused on capital planning. This programme is a follow on from Callaghan Innovation’s existing Capital Education workshop series but is tailored for the specific challenges faced by healthtech companies.
We encourage early-to mid-stage healthtech companies seeking to raise capital for the first time outside their immediate contacts, to attend.
Some of the topics that will be covered include:
Pitching a healthtech company and what investors are looking for
Developing your healthtech capital-raising strategy
Available sources of capital for healthtech companies
Covid-19 impact on healthtech investment.
9am - 1pm, Tuesday 27 April, 2021
Hosted in-person at Callaghan Innovation, 5 Sheffield Crescent, Burnside, Christchurch
Cost per person: $50 ex GST plus booking fee. The $3.37 booking fee will be donated to the Educational Equity for Maori and Pasifika Learners.
This workshop is strictly limited to a maximum of 8 companies, with an allowance of 2 people per company.
Register no later than Friday 16 April.
Facilitator bio: Tim McCready
Tim has worked in the public and private sector in New Zealand, Australia and Europe with biotech, healthtech and consumer health companies on international market development, business development and capital raising. In his role as a senior consultant at BioPacific Partners, he works with multinationals in the life sciences, helping them to access innovation in New Zealand and Australia. He also works with local innovators preparing them for deal making.
Tim recently delivered a report for the Australian health tech industry about the attitudes of multinational corporates to innovation from this side of the world. He is also a regular contributor to NZ Herald special business reports with a focus on innovation, capital markets and international trade.
Tim has a Bachelor of Science (Biological Sciences & Statistics) and a Master in Bioscience Enterprise (Hons) from the University of Auckland.
Aimed at early health tech businesses looking for investment, presenter Julia Chambers will unpack market validation (the difference for health tech), the problem context, the customer, assumptions and how to (in)validate them.